Best and Worst ETFs of 2011

By Ben Steverman - 2011-12-20T03:31:39Z

Photograph by Dr. Reddy's Laboratories Ltd. via Bloomberg

2 of 23

Biotech HOLDRs Trust

Total return: 18.4%

Fund company: Merrill Lynch

Industry focus: Health & biotechnology

Fund ticker/Total assets: BBH, $261 million

Top holdings, with 2011 total return:

Amgen (AMGN), +6.9%

Biogen Idec (BIIB), +69%

Gilead Sciences (GILD), +8.7%